Use of fused nicotinamides to promote neurogenesis
US7858628B2 · kind B2 · utility
3Cited by
29References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2009 |
| Grant date | Dec 28, 2010 |
| Priority date | — |
| Expiry date | Aug 31, 2029 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/6896
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a group of compounds found to increase the number of neurons derived from stem cells for use as a therapeutic agent in neurological conditions or diseases. In one embodiment of the present invention, the compounds are used to detect the mechanism by which the number of neurons is increased.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.